Neuroone Medical Technologies (NMTC) Accumulated Depreciation & Amortization (2020 - 2025)
Historic Accumulated Depreciation & Amortization for Neuroone Medical Technologies (NMTC) over the last 6 years, with Q4 2025 value amounting to $858768.0.
- Neuroone Medical Technologies' Accumulated Depreciation & Amortization rose 3873.29% to $858768.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $858768.0, marking a year-over-year increase of 3873.29%. This contributed to the annual value of $798823.0 for FY2025, which is 4278.46% up from last year.
- Neuroone Medical Technologies' Accumulated Depreciation & Amortization amounted to $858768.0 in Q4 2025, which was up 3873.29% from $798823.0 recorded in Q3 2025.
- Over the past 5 years, Neuroone Medical Technologies' Accumulated Depreciation & Amortization peaked at $540.0 billion during Q3 2022, and registered a low of $58492.0 during Q1 2021.
- Its 5-year average for Accumulated Depreciation & Amortization is $27.0 billion, with a median of $361523.0 in 2023.
- As far as peak fluctuations go, Neuroone Medical Technologies' Accumulated Depreciation & Amortization soared by 59960418019.48% in 2022, and later plummeted by 9999.99% in 2023.
- Over the past 5 years, Neuroone Medical Technologies' Accumulated Depreciation & Amortization (Quarter) stood at $109634.0 in 2021, then skyrocketed by 97.63% to $216667.0 in 2022, then soared by 79.11% to $388062.0 in 2023, then skyrocketed by 59.51% to $619008.0 in 2024, then skyrocketed by 38.73% to $858768.0 in 2025.
- Its last three reported values are $858768.0 in Q4 2025, $798823.0 for Q3 2025, and $740078.0 during Q2 2025.